Protein kinase B (PknB) is an essential serine/threonine protein kinase required for Mycobacterium tuberculosis (M. tb) cell division and cell-wall biosynthesis. A high throughput screen using PknB identified a (E)-4-oxo-crotonic acid inhibitor, named YH-8, which was used as a scaffold for SAR investigations. A significant improvement in enzyme affinity was achieved. The results indicated that the a,b-unsaturated ketone scaffold and "trans-" configuration are essential for the activity against PknB. And compounds with an aryl group, especially with electron-withdrawing substituents on benzene ring, exhibited four fold potency than that of YH-8.
Introduction
As an essential Mycobacterium tuberculosis (Mtb) serine/ threonine protein kinase (STPK), protein kinase B (PknB) is highly conserved in Gram-positive bacteria and apparently required for mycobacterial growth. [1] [2] [3] [4] The knockout and overexpression of PknB can lead to alteration of growth rate and cell morphology of TB. [5] [6] [7] [8] The crystal structure of the kinase domain of PknB in complexes with an ATP analogue 9 exhibits less than 30% similarity with eukaryotic and prokaryotic STPKs, which suggests that PknB may be a potential drug target for the tuberculosis kinases and not those of the host. Previously many high affinity inhibitors have also been reported for PknB. 10 Fig. 1) , was identied as a PknB inhibitor from a high throughput screen (HTS) of our compounds collection. Its majority anti-TB activity of minimum inhibitory concentrations (MICs) is falling in the 0.625-1.250 mmol L À1 range in vitro, which is signicantly higher than other reported PknB inhibitors, such as amminopyrimidines, aminoguanidines and anthraquinones classes. 11 Stability assay revealed that YH-8 was stable over 12 h in rat plasma samples, and the acute toxicity for the LD 50 values in rat were 600 mg kg À1 (orally administered) and 200 mg kg À1 (vein injected). 12 As a new unsaturated crotonic acid scaffold of YH-8 from all reported anti-TB chemical scaffolds, 10, 13 the previously results formed the starting point for our chemistry programme. In this study, we reported on the synthesis and structure-activity relationship (SAR) study of series of YH-8 derivatives as potential PknB inhibitors.
YH-8, namely (E)-methyl-4-(4-methoxyphenyl)-4-oxobut-2-enoate (

Chemical synthesis
In Scheme 1, 7 compounds were rstly designed and synthesized based on the scaffold A ((E)-a,b-unsaturated ketone, Fig. 1 ) of YH-8 for SAR investigations. g-Oxobenzenebutanoic acid 2a was prepared using Friedel-Cras acylation of anisole with succinic anhydride catalyzed by Lewis acid of aluminum chloride in 80% yield.
14 Reduction of 2a by triethylsilane in triuoroacetic acid obtained 3a in 72% yield. Methyl esters 1b, 2b and 3b were synthesized from corresponding acids 1a, 2a and 3a in methanol catalyzed by concentrated sulfuric acid in 92-95% yields. 15 According to literature method, 16 the carboxylic acid group of 1a, 2a and 3a was rstly activated by treatment with isobutylchloroformate (IBCF), the product of which was then treated in situ with ammonia gas at À15 C to give corresponding amides 1c, 2c and 3c in 75-85% yields. In Scheme 2, 
Conclusions
In summary, the starting HTS hit of YH-8 was optimized for potency against PknB, and total 87 compounds were synthesized for SAR investigations. The initial SAR study of YH-8 indicated the a,b-unsaturated ketone scaffold and "trans-" conguration are essential for the activity of YH-8 against PknB. According to this nding, other 80 YH-8 derivatives were synthesized and evaluated. The results showed that the compounds bearing an aryl group on part C and a tert- 8e  9e  10e  11e   8f  9f  10f  11f   8g  9g  10g  11g   8h  9h  10h  11h   8i  9i  10i  11i   8j  9j  10j  11j   8k  9k  10k  11k   8l  9l  10l  11l   8m  9m  10m  11m   8n  9n  10n  11n   8o  9o  10o  11o   8p  9p  10p  11p   8q  9q  10q  11Me  8r  9r  10r  11r   8s  9s  10s  11s   8t  9t  10t  11t butoxycarbonyl-aminoethyl group on part B generally showed higher potency than other compounds and YH-8. Among these compounds, 11n-o and 11p with electron-withdrawing substituents on benzene ring exhibited about fourfold more potent than that of YH-8.
Experimental section
Methods and materials
The chemicals were purchased from Aldrich Chemical Co., Sigma or Chemical Co. THF was distilled under argon from sodium-benzophenone ketyl and CH 2 Cl 2 was distilled under argon from calcium hydride. The reaction products were puried by crystallization or ash column chromatography using a mixture of petroleum ether and ethyl acetate as the eluent. (Hz) . MS data were obtained using time-of-ight mass spectrometer (TOF-MS) or Bruker microTOF-Q instrument (Bruker, Billerica, MA, USA). High resolution mass spectra (HRMS) were obtained on a Q-TOF Ultima ESI instrument (micrOTOF-Q II, Bruker Daltonics, Leipzig, Germany). Analysis by thin layer chromatography (TLC) was performed on silica gel plates (Merck, Billerica, MA, USA). Automated column chromatography was conducted over silica gel using a Companion Rf 200 automated chromatography system (Teledyne ISCO, Lincoln, NE, USA).
General synthetic procedures
Method A: general procedure for the preparation of esters (1b, 2b, 3b, 8a-t, 9a-t and 10a-t) from corresponding acids. 15 To a solution of the corresponding acid (1 equiv.) in corresponding alcohol (2 mL mmol À1 ) was added concentrated sulfuric acid (25 mL mmol À1 ). The reaction mixture was reuxed overnight, then cooled, concentrated, diluted with sat. NaHCO 3 solution, extracted with DCM, dried over Na 2 SO 4 and concentrated in vacuum. The residue was puried by ash column chromatography on silica with an elution of hexanes/EtOAc 4 : 1 to give the corresponding ester. Method B: general procedure for the preparation of amides (1c, 2c and 3c) from corresponding acids. 16 To a solution of the corresponding acid (1 equiv.) in anhydrous THF (5 mL mmol À1 )
was added triethylamine (2 equiv.) under argon atmosphere, and cooled to À15 C. Isobutylchloroformate (IBCF, 2 equiv.)
was added dropwise at a rate so as to not exceed an internal temperature of À10 C. Aer stirring for 1 h at À15 C, ammonia gas was slowly bubbled into the reaction mixture. During the bubbling, the reaction temperature rose to 0 C and kept the reaction temperature at 0 C overnight. Then the reaction mixture was diluted with EtOAc (10 mL mmol À1 ) and washed with 10% aqueous sodium chloride solution, followed by saturated brine. The organic layer was dried over Na 2 SO 4 . Aer ltration, the solvent was removed under reduced pressure to give the corresponding amide. Method C: general procedure for the preparation of E-g-oxoa,b-alkenyl acids (7a-t). 17 To a solution of glyoxylic acid (5, 1 equiv.) in acetic acid (2 mL mmol À1 ) was added corresponding methyl ketone (1 equiv.). The resulting mixture was reuxed for overnight and monitored by TLC using ethyl acetate/petroleum ether (2 : 1) as a solvent system. Aer cooling, the solvent was evaporated. The residue was washed with ice-cold water by decantation or on a lter. The crude product was dried in air at 40 C and recrystallized from ethyl acetate or puried by column chromatography over silica gel with elution of a mixture of petroleum ether and ethyl acetate (2 : 1) to give the corresponding acid. For the synthesis of compound 7s, catalytic amount of morpholine hydrochloride was used as a catalyst without acetic acid as a solvent at 120 C for overnight.
Method D: general procedure for the preparation of E-g-oxoa,b-alkenyl acids (11a-t). To a solution of 7a-t (1 equiv.) in anhydrous dichloromethane (10 mL mmol À1 ) was added triethylamine (TEA, 2 equiv.), followed by the addition dropwise of isobutylchloroformate (IBCF, 1.5 equiv.) at À15 C in nitrogen atmosphere. Aer the addition done, the resulting mixture was stirred at À15 C for further 8 h. N-Boc-ethanolamine (0.8 equiv.) was added and the reaction mixture was stirred for overnight and allowed to warm to room temperature. The reaction mixture was washed sequentially by saturated aqueous ammonium chloride and saturated brine, dried over Na 2 SO 4 . Aer ltration, the solvent was removed under reduced pressure. The residue was puried by ash column chromatography on silica with an elution of hexanes/EtOAc 4 : 1 to give the corresponding ester. 
4-(4-Methoxyphenyl)-4-oxobutanoic acid (2a).
14 To a mixture of anisole (10.8 g, 100 mmol) and anhydrous aluminum chloride (32.0 g, 240 mmol) in nitrobenzene (150 mL) at 0-5 C was added dropwise a solution of succinic anhydride (12.0 g, 120 mmol) in nitrobenzene (150 mL) and maintained the same temperature. Aer addition completed, the reaction mixture was stirred at room temperature for 1 h and then heated up to 60 C for a further 3 h. The reaction mixture was cooled, poured into ice-cold water (800 mL) and the resulting precipitate was ltered, washed with water and hexane to give a crude, which was crystallized from methanol/ethyl acetate (1 : 9) to give a colorless crystal of 2a ( 
4-(4-Methoxyphenyl) butanoic acid (3a)
. A mixture of 2a (3.12 g, 15.00 mmol) and triethylsilane (10.5 g, 90.0 mmol) in triuoroacetic acid (20 mL) was heated to 50 C under argon atmosphere for 5 h. Aer cooling, the solvent was evaporated in vacuum, then the reaction mass was diluted with water (100 mL) and EtOAc (100 mL) and stirred for 5 min. The aqueous layer was extracted with EtOAc (100 mL Â 2) and the combined organic extracts were washed with saturated brine and dried over Na 2 SO 4 . Aer ltration, the solvent was removed under reduced pressure and then co-evaporated with hexanes (50 mL). The residue was treated by ash column chromatography on silica with a elution of hexanes/EtOAc 1 : 1 to give 3a as a colorless solid (2.10 g, 72%): mp 62.5-63. (4) and (E)-methyl 4-(4-methoxyphenyl)-4-oxobut-2-enoate (8a or YH-8). To a solution of 7.40 g of glyoxylic acid (5.56 mL, 100 mmol) in acetic acid (100 mL) was added 5 (15.0 g, 100 mmol), and the resulting mixture was stirred at 120 C overnight. Aer cooling, the solvent was evaporated. The residue was washed with icecold water (50 mL) by decantation or on a lter. 
(E)-4-Cyclohexyl-4-oxobut-2-enoic acid (7s). White solid (60%
(E)-Methyl 4-(3,4-dimethoxyphenyl)-4-oxobut-2-enoate (8h). Yellow solid (46%
d 8.38-8.35 (m, 2H), 8.16-8.14 (m, 2H), 7.88 (d, J ¼ 15.6 Hz, 1H), 6.95 (d, J ¼ 15.6 Hz, 1H), 3.87 (s, 3H); HRMS (ESI) m/z calcd for
